| 000 | 01620 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515185550.0 | ||
| 264 | 0 | _c20100408 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1432-2072 | ||
| 024 | 7 |
_a10.1007/s00213-009-1652-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKumar, Puneet | |
| 245 | 0 | 0 |
_aProtective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms. _h[electronic resource] |
| 260 |
_bPsychopharmacology _cDec 2009 |
||
| 300 |
_a257-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xadministration & dosage |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aCatechin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNeurodegenerative Diseases _xetiology |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xpathology |
| 650 | 0 | 4 |
_aNeurotoxins _xtoxicity |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitro Compounds _xtoxicity |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aPropionates _xtoxicity |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 700 | 1 | _aKumar, Anil | |
| 773 | 0 |
_tPsychopharmacology _gvol. 207 _gno. 2 _gp. 257-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00213-009-1652-y _zAvailable from publisher's website |
| 999 |
_c19160919 _d19160919 |
||